Intech Biopharm Ltd (6461) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.058x

Based on the latest financial reports, Intech Biopharm Ltd (6461) has a cash flow conversion efficiency ratio of -0.058x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-64.39 Million ≈ $-2.03 Million USD) by net assets (NT$1.10 Billion ≈ $34.69 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Intech Biopharm Ltd to measure how many days the company can operate on defensive assets alone.

Intech Biopharm Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Intech Biopharm Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Intech Biopharm Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Intech Biopharm Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
XAC Automation TWO:5490	0.082x
Thai Plaspac Public Company Limited BK:TPAC	0.071x
Biomea Fusion Inc NASDAQ:BMEA	-0.623x
Oroco Resource Corp V:OCO	-0.014x
Golden Bridge Electech Inc TW:6133	0.023x
Forsys Metals Corp. TO:FSY	-0.019x
Pc Iletisim ve Medya Hizmetleri Sanayi Ticaret AS IS:PCILT	0.201x
Nuveen California Select Tax Free Income Closed Fund NYSE:NXC	-0.014x

Annual Cash Flow Conversion Efficiency for Intech Biopharm Ltd (2017–2025)

The table below shows the annual cash flow conversion efficiency of Intech Biopharm Ltd from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see 6461 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$1.10 Billion ≈ $34.69 Million	NT$-361.13 Million ≈ $-11.38 Million	-0.328x	+0.79%
2024-12-31	NT$814.28 Million ≈ $25.65 Million	NT$-269.22 Million ≈ $-8.48 Million	-0.331x	-89.15%
2023-12-31	NT$1.17 Billion ≈ $36.79 Million	NT$-204.13 Million ≈ $-6.43 Million	-0.175x	+5.28%
2022-12-31	NT$1.03 Billion ≈ $32.50 Million	NT$-190.39 Million ≈ $-6.00 Million	-0.185x	-23.05%
2021-12-31	NT$1.34 Billion ≈ $42.14 Million	NT$-200.61 Million ≈ $-6.32 Million	-0.150x	-19.06%
2020-12-31	NT$1.33 Billion ≈ $41.86 Million	NT$-167.38 Million ≈ $-5.27 Million	-0.126x	-4.52%
2019-12-31	NT$1.57 Billion ≈ $49.43 Million	NT$-189.09 Million ≈ $-5.96 Million	-0.121x	+22.84%
2018-12-31	NT$1.49 Billion ≈ $46.88 Million	NT$-232.43 Million ≈ $-7.32 Million	-0.156x	-45.69%
2017-12-31	NT$1.36 Billion ≈ $42.70 Million	NT$-145.29 Million ≈ $-4.58 Million	-0.107x	--

About Intech Biopharm Ltd

TWO:6461 Taiwan Biotechnology

Market Cap

$85.97 Million

NT$2.73 Billion TWD

Market Cap Rank

#19867 Global

#1168 in Taiwan

Share Price

NT$15.30

Change (1 day)

+0.00%

52-Week Range

NT$14.40 - NT$25.05

All Time High

NT$57.64